diabetes

Lilly Beefs Up Diabetes Pipeline With Boehringer Deal
Seeking Alpha
Sun, 01/16/11 - 11:38 am
Eli Lilly
Boehringer Ingelheim
diabetes
Eli Lilly, Boehringer Ingelheim launch collaboration to develop diabetes treatments
Yahoo/AP
Tue, 01/11/11 - 12:45 pm
Eli Lilly
Boehringer Ingelheim
diabetes
Merck Reports FDA Acceptance of NDA for Janumet
Bloomberg
Tue, 01/11/11 - 12:41 pm
Merck
FDA
Janumet
NDA
diabetes
New Langer startup to develop oral insulin
Bizjournals.com
Mon, 01/10/11 - 12:27 pm
insulin
diabetes
Entrega
A Biotech Roller Coaster
Motley Fool
Sat, 01/8/11 - 11:57 am
Lexicon Pharmaceuticals
diabetes
LX4211
Merck
obesity
Amylin
Januvia
Onglyza
Bristol-Myers Squibb
AstraZeneca
Lexicon Pharma shares soar after study reported
Yahoo/AP
Fri, 01/7/11 - 07:18 am
Lexicon Pharmaceuticals
diabetes
LX4211
NeuroMetrix disbands direct sales, lays off 27 percent of workers
Wed, 01/5/11 - 04:53 pm
NeuroMetrix
diabetes
diabetic neuropathy
layoffs
Mann doubles down on biotech as Afrezza decision looms
Fierce Biotech
Wed, 01/5/11 - 11:49 am
diabetes
MannKind
inhaled insulin
Afrezza
NeuroMetrix Announces New Strategic Direction
Tue, 01/4/11 - 05:36 pm
NeuroMetrix
diabetes
Xoma: Key Diabetes Drug Study Preview
TheStreet.com
Tue, 01/4/11 - 09:34 am
Xoma
diabetes
XOMA 052
Abbott recalls 359 million blood glucose test strips
Thu, 12/23/10 - 07:36 pm
Abbott Laboratories
glucose test strips
diabetes
Precision Xtra
Precision Xceed Pro
MediSense Optium
Optium
OptiumEZ
ReliOn Ultima
Teva will market generic Actos starting in 2012
Yahoo/AP
Tue, 12/21/10 - 05:46 pm
generics
Actos
Teva Pharmaceuticals
Takeda
diabetes
Xoma shares rocket on diabetes drug research report
Bizjournals.com
Tue, 12/21/10 - 04:32 pm
diabetes
Xoma
XOMA 052
IL-1 inhibitor
MedImmune inks $342M collaboration on diabetes program
Fierce Biotech
Thu, 12/16/10 - 01:11 pm
MedImmune
diabetes
Evotec
Neutral on MannKind
Yahoo/Zacks
Sat, 12/11/10 - 11:39 am
MannKind
Afrezza
inhaled insulin
diabetes
China's Type 2 Diabetes Market Will Grow to $2.5 Billion in 2014
PR-Canada
Sun, 12/5/10 - 12:20 pm
China
type 2 diabetes
diabetes
Merck Makes Insulin Play: Biotech Transactions Heat Up
Seeking Alpha
Sun, 12/5/10 - 11:58 am
Merck
SmartCells
insulin
diabetes
Merck & Co. buying SmartCells for $500 million
Marketwatch
Thu, 12/2/10 - 09:20 am
SmartCells
M&A
Merck
diabetes
China's Diabetes-Drug Market to Reach $2 Billion by 2019, Datamonitor Says
Bloomberg
Mon, 11/22/10 - 10:20 am
diabetes
China
Halozyme's rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
Yahoo/PR NewsWire
Sat, 11/13/10 - 12:04 pm
Halozyme
Lispro
diabetes
insulin

Pages